# Refine USA, LLC – FDA Inspection, Aug 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/refine-usa-llc/25957ef7-6a47-46c8-b460-87533d172717
Source feed: FDA_Inspections

> FDA inspection 1215028 of Refine USA, LLC, August 16, 2023. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215028
- Company Name: Refine USA, LLC
- Inspection Date: 2023-08-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 1

## Related Documents

- [FDA Inspection 1049482 - 2018-04-18](https://www.keypedia.com/records/fda_inspections/refine-usa-llc/8f893699-8f3d-4230-b4cb-a24bb66f41a0)
- FDA Inspection 852060 - 2013-10-04

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/alex-j-wild/bb1b66b3-19b9-480e-af0b-f06f8de0d930)

Company: https://www.keypedia.com/companies/refine-usa-llc/52f6174e-99ed-4128-9380-d6434537b084

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
